Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BNTC
- Price
- 12.63
- Stock movement up
- +0.69 (5.78%)
- Company name
- Benitec Biopharma Ltd ADR
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 250.26M
- Ent value
- 187.02M
- Price/Sales
- 41710.57
- Price/Book
- 3.90
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 110.85%
- 3 year return
- -29.27%
- 5 year return
- -33.88%
- 10 year return
- -43.41%
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
BNTC does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 41710.57 |
| Price to Book | 3.90 |
| EV to Sales | 31169.41 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 19.82M |
| EPS (TTM) | -1.96 |
| FCF per share (TTM) | -1.85 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 6.00K |
| Gross profit (TTM) | -176.00K |
| Operating income (TTM) | -22.41M |
| Net income (TTM) | -20.86M |
| EPS (TTM) | -1.96 |
| EPS (1y forward) | -1.81 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -2933.33% |
| Operating margin (TTM) | -214748.36% |
| Profit margin (TTM) | -214748.36% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 67.84M |
| Net receivables | 4.00K |
| Total current assets | 68.33M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 1.79M |
| Total assets | 68.77M |
| Accounts payable | 903.00K |
| Short/Current long term debt | 211.00K |
| Total current liabilities | 4.55M |
| Total liabilities | 4.59M |
| Shareholder's equity | 64.18M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -19.48M |
| Capital expenditures (TTM) | 179.99K |
| Free cash flow (TTM) | -19.66M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -32.50% |
| Return on Assets | -30.33% |
| Return on Invested Capital | -32.39% |
| Cash Return on Invested Capital | -30.53% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 11.88 |
| Daily high | 12.87 |
| Daily low | 11.49 |
| Daily Volume | 55K |
| All-time high | 5598.27 |
| 1y analyst estimate | 24.00 |
| Beta | 0.88 |
| EPS (TTM) | -1.96 |
| Dividend per share | - |
| Ex-div date | 1 Jun 2018 |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| BNTC | S&P500 | |
| Current price drop from All-time high | -99.77% | -12.89% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 8 Aug 2023 | 9 Mar 2009 |
| Avg drop from high | -89.20% | -11.07% |
| Avg time to new high | 527 days | 12 days |
| Max time to new high | 2604 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
250.26M
Marketcap category
Small-cap
Description
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.
Employees
16
Website
Investor relations
-
SEC filings
CEO
Jerel A. Banks
Country
USA
City
Melbourne
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page